IP Library Granted Patent US 10,632,095
Granted Patent B2
US 10,632,095 · App. 15/102,020 · Granted Apr 28, 2020

Long-acting ketoprofen compositions

Inventors: Richard Andrew Ewin (Kalamazoo, MI); Steven X. Hu (Kalamazoo, MI); Susan M. Machkovech (Kalamazoo, MI); Barton H. Manning (Kalamazoo, MI); Stephen Lee Secreast (Kalamazoo, MI)
Assignee: Zoetis Services LLC
A61K31/216A61K9/0019A61K9/0024A61K47/10A61K47/14A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,095
App. No.
15/102,020
Granted
Apr 28, 2020
Kind
B2
Abstract

The invention describes a long-acting veterinary composition comprising at least one ketoprofen ester prodrug. The composition also comprises at least one veterinary acceptable triglyceride, and optionally, at least one preservative, and optionally, at least one additional veterinary acceptable excipient. The invention also describes a method of treating an animal for fever, pain, and/or inflammation by administering the long-acting composition comprising at least one ketoprofen ester prodrug to the animal in need thereof.

Claims (7)

1. An injectable veterinary long-acting composition comprising

a) a ketoprofen methyl ester prodrug in the amount of about 20-300 mg/mL; b) a veterinary acceptable triglyceride that is a caprylic/capric acid triglyceride;

c) at least one preservative, and

d) a veterinary acceptable excipient that is a solvent selected from the group consisting of benzyl benzoate, polyethylene glycol, N,N-dimethylyacetamide, propylene glycol, ethanol, benzyl alcohol, dimethyl sulfoxide, N-methylpyrrolidone, 2-pyrrolidone, glycerol formal, glycerol, isopropyl myristate, tetraglycol, diethylene glycol monoethyl ether and diethylene glycol monomethyl ether; and wherein said composition provides for the treatment of pain, inflammation, and/or fever reduction for up to 120 hours following a single injectable dose.

2. The veterinary long-acting composition of claim 1 wherein the veterinary acceptable solvent is benzyl benzoate.

3. The veterinary long-acting composition of claim 2 wherein the veterinary acceptable caprylic/capric triglyceride is Miglyol 812.

4. The veterinary long-acting composition of claim 1 wherein the at least one preservative is benzyl alcohol.

Assignments (3)
ADDRESS CHANGE OF ASSIGNEE Recorded Jun 5, 2017
From: ZOETIS SERVICES LLC
To: ZOETIS SERVICES LLC
Reel/Frame 042684/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2016
From: EWIN, RICHARD ANDREW; HU, STEVEN X.; MACHKOVECH, SUSAN M.; MANNING, BARTON H.; SECREAST, STEPHEN LEE
To: ZOETIS LLC
Reel/Frame 039245/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2016
From: ZOETIS LLC
To: ZOETIS SERVICES LLC
Reel/Frame 039460/0443 →